Trademark: AMTAGVI
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for AMTAGVI
We do not have any records of a proof of use for AMTAGVI at this moment.
Possible trademark infringements of AMTAGVI
Basic Information about AMTAGVI
- Serial Number
- 88918260
- Filing Date
- 15 May 2020
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of AMTAGVI on the blockchain with WikiTrademarks.io.
- First use of AMTAGVI anywhere
- AMTAGVI was first used on 22 Nov 2023 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
- First use of AMTAGVI anywhere
- AMTAGVI was first used on 21 Nov 2023 for the primary classification of goods and services, international, 044 (Medical, beauty & agricultural)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 044
- US Codes
- 100; 101
Who owns AMTAGVI?
1. Iovance Biotherapeutics, Inc. San Carlos CA
2. Iovance Biotherapeutics, Inc. San Carlos CA
Correspondent
- Carla B. Oakley MORGAN, LEWIS & BOCKIUS LLP
- ONE MARKET, SPEAR STREET TOWER
- SAN FRANCISCO, CA 94105
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io